UCP2 -866G/A and Ala55Val, and UCP3 -55C/T polymorphisms in association with type 2 diabetes susceptibility: A meta-analysis study

Diabetologia

Volumn 54, Issue 9, 2011, Pages 2315-2324

  Xu, K ^a   Zhang, M ^a   Cui, D ^a   Fu, Y ^a   Qian, L ^a   Gu, R ^a   Wang, M ^a   Shen, C ^a   Yu, R ^a   Yang, T ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Polymorphism; Type 2 diabetes; UCP2; UCP3

Indexed keywords

ALANINE; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3; VALINE;

ARTICLE; ASIAN; DISEASE PREDISPOSITION; ETHNIC GROUP; ETHNICITY; EUROPEAN; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PUBLISHING; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ION CHANNELS; MITOCHONDRIAL PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 80054700055     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2245-y     Document Type: Article

References (48)

1. Dalgaard LT, Pedersen O (2001) Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type II diabetes. Diabetologia 44:946-965 (Pubitemid 32778126)
2. Fleury C, Neverova M, Collins S et al (1997) Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15:269-272 (Pubitemid 27098720)
3. Solanes G, Vidal-Puig A, Grujic D, Flier JS, Lowell BB (1997) The human uncoupling protein-3 gene. Genomic structure, chromosomal localization, and genetic basis for short and long form transcripts. J Biol Chem 272:25433-25436 (Pubitemid 27438845)
4. Krauss S, Zhang CY, Lowell BB (2005) The mitochondrial uncoupling-protein homologues. Nat Rev Mol Cell Biol 6:248-261 (Pubitemid 40314925)
5. Chan CB, Kashemsant N (2006) Regulation of insulin secretion by uncoupling protein. Biochem Soc Trans 34:802-805 (Pubitemid 44796425)
6. de Souza CT, Araujo EP, Stoppiglia LF et al (2007) Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion and action. FASEB J 21:1153-1163 (Pubitemid 46495705)
7. Chan CB, DeLeo D, Joseph JWet al (2001) Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucosestimulated insulin secretion: mechanism of action. Diabetes 50:1302-1310 (Pubitemid 32500162)
8. Zhang CY, Baffy G, Perret P et al (2001) Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105:745-755 (Pubitemid 32635104)
9. Krook A, Digby J, O'Rahilly S, Zierath JR, Wallberg-Henriksson H (1998) Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients. Diabetes 47:1528-1531 (Pubitemid 28396961)
10. Jia JJ, Zhang X, Ge CR, Jois M (2009) The polymorphisms of UCP2 and UCP3 genes associated with fat metabolism, obesity and diabetes. Obes Rev 10:519-552
11. Krempler F, Esterbauer H, Weitgasser R et al (2002) A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes 51:3331-3335 (Pubitemid 35246982)
12. Esterbauer H, Schneitler C, Oberkofier H et al (2001) A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 28:178-183 (Pubitemid 32538066)
13. D'Adamo M, Perego L, Cardellini M et al (2004) The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. Diabetes 53:1905-1910 (Pubitemid 38857052)
14. Sasahara M, Nishi M, Kawashima H et al (2004) Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients. Diabetes 53:482-485 (Pubitemid 38174566)
15. Sesti G, Cardellini M, Marini MA et al (2003) A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes 52:1280-1283 (Pubitemid 36523369)
16. Astrup A, Toubro S, Dalgaard LT, Urhammer SA, Sorensen TI, Pedersen O (1999) Impact of the v/v 55 polymorphism of the uncoupling protein 2 gene on 24-h energy expenditure and substrate oxidation. Int J Obes Relat Metab Disord 23:1030-1034 (Pubitemid 29476205)
17. Yu X, Jacobs DR, Schreiner PJ, Gross MD, Steffes MW, Fornage M (2005) The uncoupling protein 2 Ala55Val polymorphism is associated with diabetes mellitus: the CARDIA Study. Clin Chem 51:1451-1456 (Pubitemid 41060877)
18. Walder K, Norman RA, Hanson RL et al (1998) Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima Indians. Hum Mol Genet 7:1431-1435 (Pubitemid 28429924)
19. Meirhaeghe A, Amouyel P, Helbecque N et al (2000) An uncoupling protein 3 gene polymorphism associated with a lower risk of developing type II diabetes and with atherogenic lipid profile in a French cohort. Diabetologia 43:1424-1428
20. Parmar MKB, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815-2834 (Pubitemid 28562978)
21. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558 (Pubitemid 34746062)
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta analyses. BMJ 327:557-560
23. Dupont WD, Plummer WD Jr (1990) Power and sample size calculations. A review and computer program. Control Clin Trials 11:116-128 (Pubitemid 20136185)
24. Wacholder S, Chanock S, Garcia-Closas M, ElGhormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-442 (Pubitemid 38443646)
25. Harbord RM, Egger M, Sterne JA (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25:3443-3457 (Pubitemid 44575162)
26. Wang H, Chu WS, Lu T, Hasstedt SJ, Kern PA, Elbein SC (2004) Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. Am J Physiol Endocrinol Metab 286:E1-E7 (Pubitemid 38036602)
27. Ji Q, Ikegami H, Fujisawa T et al (2004) A common polymorphism of uncoupling protein 2 gene is associated with hypertension. J Hypertens 22:97-102 (Pubitemid 38293536)
28. Bulotta A, Ludovico O, Coco A et al (2005) The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy. J Clin Endocrinol Metab 90:1176-1180 (Pubitemid 40279251)
29. Pinelli M, Giacchetti M, Acquaviva F et al (2006) Beta2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus. BMC Med Genet 7:85
30. Hsu YH, Niu T, Song Y, Tinker L, Kuller LH, Liu S (2008) Genetic variants in the UCP2-UCP3 gene cluster and risk of diabetes in the women's health initiative observational study. Diabetes 57:1101-1107
31. Lee HJ, Ryu HJ, Shin HD et al (2008) Associations between polymorphisms in the mitochondrial uncoupling proteins (UCPs) with T2DM. Clin Chim Acta 398:27-33
32. Beitelshees AL, Finck BN, Leone TC et al (2010) Interaction between the UCP2 -866G>A polymorphism, diabetes, and betablocker use among patients with acute coronary syndromes. Pharmacogenet Genomics 20:231-238
33. Heidari J, Akrami SM, Heshmat R, Amiri P, Fakhrzadeh H, Pajouhi M (2010) Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study. Arch Iran Med 13:384-390
34. Voight BF, Scott LJ, Steinthorsdottir Vet al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579-589
35. Vimaleswaran KS, Radha V, Ghosh S,Majumder PP, Sathyanarayana Rao MR, Mohan V (2011) Uncoupling protein 2 and 3 gene polymorphisms and their association with type 2 diabetes in Asian Indians. Diabetes Technol Ther 13:19-25
36. Kubota T, Mori H, Tamori Yet al (1998) Molecular screening of uncoupling protein 2 gene in patients with noninsulin-dependent diabetes mellitus or obesity. J Clin Endocrinol Metab 83:2800-2804 (Pubitemid 28493779)
37. Cho YM, Ritchie MD, Moore JH et al (2004) Multifactordimensionality reduction shows a two-locus interaction associated with type 2 diabetes mellitus. Diabetologia 47:549-554 (Pubitemid 38491253)
38. Dalgaard LT, Hansen T, Urhammer SA, Drivsholm T, Borch-Johnsen K, Pedersen O (2001) The uncoupling protein 3-55 C>T variant is not associated with Type II diabetes mellitus in Danish subjects. Diabetologia 44:1065-1067 (Pubitemid 32778143)
39. Saxena R, Voight BF, Lyssenko V et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331-1336 (Pubitemid 46871653)
40. Scott LJ, Mohlke KL, Bonnycastle LL et al (2007) A genomewide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341-1345 (Pubitemid 46871655)
41. Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661-678
42. Zeggini E, Weedon MN, Lindgren CM et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336-1341 (Pubitemid 46871654)
43. Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881-885
44. McCarthy MI (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363:2339-2350
45. Munafo MR, Flint J (2008) Meta-analysis of genetic association studies. Trends Genet 20:439-444 (Pubitemid 39094573)
46. Patsopoulos NA, Evangelou E, Ioannidis JP (2008) Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 37:1148-1157
47. Crispim D, Fagundes NJ, dos Santos KG et al (2010) Polymorphisms of the UCP2 gene are associated with proliferative diabetic retinopathy in patients with diabetes mellitus. Clin Endocrinol (Oxf) 72:612-619
48. Cheurfa N, Dubois-Laforgue D, Ferrarezi DA et al (2008) The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men. Diabetes 57:1063-1068